Captrust Financial Advisors Rocket Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$7.96 - $16.64 $827 - $1,730	104 New	104 $1,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $513 - $923	-39 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $387 - $648	18 Added 85.71%	39 $1,000
Q3 2021 Nov 16, 2021	SELL	$27.42 - $48.97 $575 - $1,028	-21 Reduced 50.0%	21 $1,000
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $1,339 - $1,606	-34 Reduced 44.74%	42 $2,000
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $3,293 - $5,009	76 New	76 $3,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.